Skip to main content

Table 1 Gene specific primers used to assess the anti-inflammatory effect of BAF

From: Evaluation of in vitro and in vivo anti-inflammatory activity of biologically active phospholipids with anti-neoplastic potential in porcine model

Gene

Primer sequence (5′ - 3′)

Gene characteristic/Primer reference

IL-1β/LAFa

F: GGGACTTGAAGAGAGAAGTGG

Pro-inflammatory/[31]

R: CTTTCCCTTGATCCCTAAGGT

TNF-α/TNFSF2b

F: CCCCCAGAAGGAAGAGTTTC

Pro-inflammatory/[32]

R: CGGGCTTATCTGAGGTTTGA

CXCL10/IP10c

F: CCCACATGTTGAGATCATTGC

Pro-inflammatory/[33]

R: CATCCTTATCAGTAGTGCCG

IL-10/B-TCGFd

F: TGAAGAGTGCCTTTAGCAAGCTC

Anti-inflammatory/[34]

R: CTCATCTTCATCGTCATGTAGGC

Arg1/Type I arginase

F: CCAGTCCATGGAGGTCTGTC

Anti-inflammatory/[34]

R: GTGTCTTCCCCAGAGATGGA

TBP-1

F: AACAGTTCAGTAGTTATGAGCCAGA

Reference gene, RNApolymerase II transcription initiation/[35]

R: AGATGTTCTCAAACGCTTCG

HMBS-2

F: AGGATGGGCAACTCTACCTG

Reference gene, heme biosynthesis/[35]

R: GATGGTGGCCTGCATAGTCT

HPRT-1

F: GAGCTACTGtAATGACCAGTCAACG

Reference gene, purine ribonucleoside salvage/[36]

R: CCAGTGTCAATTATATCtTCAACAATCAA

  1. aLAF = Lymphocyte-activating factor, bTNFSF2 = TNF ligand superfamily member 2, cIP10 = Interferon gamma-induced protein 10, dB-TCGF = B-cell derived T-cell growth factor. F = Forward primer, R = Reverse primer.